FDA green lights next-gen sequencing platform for drug-resistant HIV
The agency announced it had authorized Vela Diagnostics' Sentosa SQ HIV Genotyping Assay, designed to help healthcare providers tailor antiviral therapy based on the presence of viral resistance mutations.